| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonic Neoplasms | 31 | 2014 | 592 | 4.040 |
Why?
|
| ErbB Receptors | 10 | 2014 | 517 | 2.150 |
Why?
|
| Colitis | 10 | 2014 | 265 | 1.490 |
Why?
|
| Ursodeoxycholic Acid | 6 | 2010 | 26 | 1.270 |
Why?
|
| Isoenzymes | 17 | 2003 | 272 | 1.160 |
Why?
|
| Protein Kinase C | 21 | 2012 | 267 | 1.120 |
Why?
|
| Azoxymethane | 18 | 2011 | 84 | 1.050 |
Why?
|
| Colon | 23 | 2013 | 566 | 1.000 |
Why?
|
| Receptors, Calcitriol | 7 | 2014 | 130 | 0.930 |
Why?
|
| Cyclooxygenase 2 | 8 | 2010 | 101 | 0.900 |
Why?
|
| Calcitriol | 17 | 2007 | 174 | 0.890 |
Why?
|
| Down-Regulation | 9 | 2013 | 529 | 0.870 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2014 | 466 | 0.700 |
Why?
|
| Apoptosis | 11 | 2014 | 1754 | 0.680 |
Why?
|
| Colorectal Neoplasms | 9 | 2014 | 1120 | 0.680 |
Why?
|
| Genes, ras | 7 | 2008 | 97 | 0.660 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2011 | 1400 | 0.650 |
Why?
|
| Cyclin D1 | 8 | 2008 | 86 | 0.650 |
Why?
|
| Cell Proliferation | 10 | 2014 | 1801 | 0.650 |
Why?
|
| Adenocarcinoma | 7 | 2011 | 1215 | 0.630 |
Why?
|
| Precancerous Conditions | 4 | 2012 | 221 | 0.550 |
Why?
|
| Benzenesulfonates | 2 | 2008 | 49 | 0.530 |
Why?
|
| Caco-2 Cells | 13 | 2012 | 128 | 0.530 |
Why?
|
| MicroRNAs | 3 | 2011 | 609 | 0.530 |
Why?
|
| Paramyxovirinae | 2 | 2008 | 2 | 0.530 |
Why?
|
| Colitis, Ulcerative | 4 | 2013 | 844 | 0.520 |
Why?
|
| Membrane Fusion | 2 | 2008 | 37 | 0.520 |
Why?
|
| beta Catenin | 7 | 2012 | 269 | 0.480 |
Why?
|
| Intestinal Mucosa | 12 | 2014 | 846 | 0.480 |
Why?
|
| Tetradecanoylphorbol Acetate | 9 | 2006 | 122 | 0.470 |
Why?
|
| Pyridines | 2 | 2008 | 317 | 0.470 |
Why?
|
| Dextran Sulfate | 6 | 2013 | 73 | 0.460 |
Why?
|
| Cholecalciferol | 3 | 2007 | 37 | 0.450 |
Why?
|
| Signal Transduction | 15 | 2014 | 3642 | 0.450 |
Why?
|
| Rats | 31 | 2012 | 4079 | 0.440 |
Why?
|
| Animals | 52 | 2014 | 29045 | 0.430 |
Why?
|
| Receptor Cross-Talk | 1 | 2014 | 32 | 0.420 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2014 | 7 | 0.410 |
Why?
|
| Renin-Angiotensin System | 1 | 2014 | 86 | 0.410 |
Why?
|
| Panax | 3 | 2014 | 171 | 0.400 |
Why?
|
| Plant Extracts | 2 | 2014 | 252 | 0.390 |
Why?
|
| Barrett Esophagus | 3 | 2012 | 94 | 0.380 |
Why?
|
| G1 Phase | 4 | 2011 | 66 | 0.370 |
Why?
|
| NF-kappa B | 5 | 2014 | 424 | 0.360 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 36 | 0.360 |
Why?
|
| Esophageal Neoplasms | 3 | 2012 | 355 | 0.350 |
Why?
|
| Cell Line, Tumor | 10 | 2014 | 2913 | 0.350 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2012 | 123 | 0.350 |
Why?
|
| Viral Fusion Proteins | 2 | 2008 | 10 | 0.350 |
Why?
|
| Stromal Cells | 1 | 2012 | 153 | 0.340 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2008 | 15 | 0.340 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2009 | 119 | 0.330 |
Why?
|
| Proto-Oncogenes | 1 | 2011 | 60 | 0.330 |
Why?
|
| Dietary Fats | 1 | 2011 | 135 | 0.330 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2011 | 44 | 0.320 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 72 | 0.320 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 156 | 0.320 |
Why?
|
| Antineoplastic Agents | 4 | 2014 | 2386 | 0.320 |
Why?
|
| Mice | 19 | 2014 | 12762 | 0.310 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2011 | 81 | 0.310 |
Why?
|
| Up-Regulation | 6 | 2013 | 742 | 0.300 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2009 | 49 | 0.300 |
Why?
|
| Cell Division | 7 | 2007 | 690 | 0.300 |
Why?
|
| Rats, Inbred F344 | 11 | 2008 | 161 | 0.290 |
Why?
|
| Calcium | 8 | 2012 | 1205 | 0.280 |
Why?
|
| Disease Models, Animal | 9 | 2014 | 2581 | 0.280 |
Why?
|
| Lithocholic Acid | 1 | 2008 | 2 | 0.270 |
Why?
|
| Blotting, Western | 7 | 2011 | 779 | 0.270 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2014 | 186 | 0.270 |
Why?
|
| Diet | 1 | 2011 | 472 | 0.270 |
Why?
|
| Carcinogens | 4 | 2007 | 102 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2008 | 218 | 0.260 |
Why?
|
| Protein Kinase C-delta | 3 | 2006 | 29 | 0.260 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2008 | 470 | 0.250 |
Why?
|
| Transcriptome | 1 | 2013 | 828 | 0.250 |
Why?
|
| Humans | 50 | 2014 | 98799 | 0.240 |
Why?
|
| Collagen Type I | 1 | 2006 | 75 | 0.240 |
Why?
|
| Mutation | 9 | 2008 | 4443 | 0.230 |
Why?
|
| Inflammation | 2 | 2012 | 1134 | 0.220 |
Why?
|
| Transfection | 5 | 2012 | 884 | 0.220 |
Why?
|
| Chemoprevention | 4 | 2010 | 93 | 0.220 |
Why?
|
| Adenoma | 2 | 2007 | 262 | 0.220 |
Why?
|
| Enzyme Activation | 14 | 2014 | 679 | 0.200 |
Why?
|
| RNA, Messenger | 7 | 2011 | 2076 | 0.200 |
Why?
|
| Immunohistochemistry | 6 | 2013 | 1818 | 0.200 |
Why?
|
| Male | 35 | 2013 | 47475 | 0.200 |
Why?
|
| HCT116 Cells | 3 | 2013 | 164 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 642 | 0.190 |
Why?
|
| Anticarcinogenic Agents | 5 | 2006 | 71 | 0.190 |
Why?
|
| Cholagogues and Choleretics | 1 | 2002 | 10 | 0.190 |
Why?
|
| Case-Control Studies | 3 | 2013 | 2017 | 0.190 |
Why?
|
| Cadherins | 2 | 2006 | 189 | 0.180 |
Why?
|
| Biomarkers, Tumor | 3 | 2011 | 1786 | 0.170 |
Why?
|
| Transcription Factors | 4 | 2014 | 1724 | 0.170 |
Why?
|
| Trans-Activators | 2 | 2002 | 447 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 9 | 2013 | 3628 | 0.170 |
Why?
|
| Food-Processing Industry | 1 | 2001 | 3 | 0.170 |
Why?
|
| Mice, Knockout | 6 | 2014 | 2217 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2008 | 160 | 0.170 |
Why?
|
| Food Preferences | 1 | 2001 | 28 | 0.170 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 301 | 0.160 |
Why?
|
| Cells, Cultured | 8 | 2012 | 2859 | 0.160 |
Why?
|
| Ginsenosides | 2 | 2012 | 124 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2011 | 76 | 0.160 |
Why?
|
| Polyethylene Glycols | 3 | 2008 | 383 | 0.160 |
Why?
|
| Models, Psychological | 1 | 2001 | 166 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 1 | 2002 | 357 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 100 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 369 | 0.150 |
Why?
|
| Adolescent Behavior | 1 | 2001 | 118 | 0.150 |
Why?
|
| Interleukin-1beta | 2 | 2012 | 92 | 0.150 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 1136 | 0.150 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 1999 | 117 | 0.150 |
Why?
|
| Environment | 1 | 2001 | 233 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2003 | 1256 | 0.140 |
Why?
|
| Cyclin E | 3 | 2008 | 28 | 0.140 |
Why?
|
| Snail Family Transcription Factors | 3 | 2014 | 47 | 0.140 |
Why?
|
| Genes, APC | 2 | 2011 | 25 | 0.140 |
Why?
|
| RNA, Small Interfering | 4 | 2010 | 573 | 0.140 |
Why?
|
| Reference Values | 4 | 2008 | 608 | 0.140 |
Why?
|
| Quinazolines | 3 | 2008 | 222 | 0.130 |
Why?
|
| Niacinamide | 2 | 2008 | 105 | 0.130 |
Why?
|
| STAT3 Transcription Factor | 2 | 2008 | 91 | 0.130 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2008 | 36 | 0.130 |
Why?
|
| Phenylurea Compounds | 2 | 2008 | 112 | 0.130 |
Why?
|
| Intestinal Neoplasms | 2 | 2011 | 77 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 125 | 0.130 |
Why?
|
| Mice, Inbred A | 2 | 2007 | 21 | 0.130 |
Why?
|
| Type C Phospholipases | 1 | 1997 | 26 | 0.130 |
Why?
|
| Intracellular Membranes | 2 | 1994 | 113 | 0.130 |
Why?
|
| src-Family Kinases | 1 | 1997 | 70 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 6 | 2011 | 1029 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 2 | 2014 | 1422 | 0.120 |
Why?
|
| Cell Growth Processes | 2 | 2006 | 83 | 0.120 |
Why?
|
| Tight Junctions | 3 | 2013 | 158 | 0.120 |
Why?
|
| Neoplasms, Experimental | 2 | 2011 | 263 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2008 | 213 | 0.120 |
Why?
|
| Cyclins | 3 | 2008 | 80 | 0.120 |
Why?
|
| HT29 Cells | 3 | 2014 | 51 | 0.110 |
Why?
|
| Epithelial Cells | 6 | 2013 | 710 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2011 | 1949 | 0.110 |
Why?
|
| Kinetics | 9 | 1999 | 1478 | 0.110 |
Why?
|
| Cell Differentiation | 7 | 2014 | 1656 | 0.110 |
Why?
|
| Guanylate Cyclase | 4 | 1994 | 19 | 0.110 |
Why?
|
| Titanium | 1 | 2014 | 27 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 2 | 2008 | 68 | 0.110 |
Why?
|
| Enteritis | 1 | 2014 | 23 | 0.100 |
Why?
|
| Angiotensin II | 1 | 2014 | 96 | 0.100 |
Why?
|
| Enzyme Inhibitors | 5 | 2006 | 641 | 0.100 |
Why?
|
| Telomere-Binding Proteins | 1 | 2014 | 14 | 0.100 |
Why?
|
| Telomere Homeostasis | 1 | 2014 | 32 | 0.100 |
Why?
|
| Analysis of Variance | 3 | 2008 | 890 | 0.100 |
Why?
|
| Disease Progression | 3 | 2012 | 1621 | 0.100 |
Why?
|
| Oligonucleotides | 1 | 2014 | 93 | 0.100 |
Why?
|
| Cell Nucleus | 2 | 2002 | 616 | 0.100 |
Why?
|
| Cholic Acid | 2 | 2008 | 8 | 0.100 |
Why?
|
| Base Sequence | 2 | 2008 | 2224 | 0.090 |
Why?
|
| Bradykinin | 1 | 1992 | 45 | 0.090 |
Why?
|
| DNA, Complementary | 1 | 2013 | 380 | 0.090 |
Why?
|
| Estrogen Receptor beta | 1 | 2012 | 26 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2012 | 175 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2013 | 471 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 2077 | 0.090 |
Why?
|
| Peptide Hormones | 1 | 2012 | 30 | 0.090 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 2897 | 0.090 |
Why?
|
| Adipokines | 1 | 2011 | 20 | 0.090 |
Why?
|
| Female | 9 | 2014 | 51997 | 0.080 |
Why?
|
| Lectins | 1 | 2011 | 83 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2011 | 44 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 375 | 0.080 |
Why?
|
| Phospholipase D | 3 | 1999 | 13 | 0.080 |
Why?
|
| Fatty Acids, Volatile | 1 | 2011 | 35 | 0.080 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2012 | 67 | 0.080 |
Why?
|
| Cetuximab | 1 | 2011 | 119 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 700 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 306 | 0.080 |
Why?
|
| Macrophages | 1 | 2014 | 641 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 2 | 2002 | 225 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 140 | 0.080 |
Why?
|
| Butyrates | 1 | 2011 | 62 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 356 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2011 | 229 | 0.080 |
Why?
|
| GTP-Binding Proteins | 3 | 1999 | 150 | 0.080 |
Why?
|
| Phosphatidylcholines | 2 | 1999 | 49 | 0.080 |
Why?
|
| Vitamin D | 2 | 2007 | 287 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2012 | 480 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 1572 | 0.080 |
Why?
|
| Phosphorylation | 5 | 2012 | 1148 | 0.070 |
Why?
|
| Splints | 1 | 1989 | 11 | 0.070 |
Why?
|
| Finger Injuries | 1 | 1989 | 13 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2013 | 685 | 0.070 |
Why?
|
| Dietary Supplements | 2 | 2008 | 152 | 0.070 |
Why?
|
| Carcinoma | 1 | 2012 | 442 | 0.070 |
Why?
|
| HN Protein | 1 | 2008 | 4 | 0.070 |
Why?
|
| Tendon Injuries | 1 | 1989 | 39 | 0.070 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1989 | 41 | 0.070 |
Why?
|
| Point Mutation | 1 | 2009 | 236 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2009 | 102 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2010 | 199 | 0.070 |
Why?
|
| Vero Cells | 1 | 2008 | 100 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2006 | 25 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2006 | 21 | 0.070 |
Why?
|
| Cyclin D | 1 | 2008 | 15 | 0.070 |
Why?
|
| Microvilli | 1 | 1988 | 44 | 0.070 |
Why?
|
| Ligands | 1 | 2009 | 492 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2012 | 1397 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 1988 | 129 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 405 | 0.070 |
Why?
|
| Clone Cells | 1 | 2008 | 223 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2011 | 991 | 0.070 |
Why?
|
| DNA Primers | 1 | 2008 | 530 | 0.070 |
Why?
|
| Middle Aged | 5 | 2013 | 29642 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2008 | 520 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 483 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 1335 | 0.060 |
Why?
|
| Pancreas | 1 | 1989 | 269 | 0.060 |
Why?
|
| Phosphoric Diester Hydrolases | 3 | 1997 | 25 | 0.060 |
Why?
|
| Kidney | 1 | 1992 | 1126 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 733 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2009 | 392 | 0.060 |
Why?
|
| Bacteria | 1 | 2011 | 547 | 0.060 |
Why?
|
| Probability | 1 | 2008 | 356 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 583 | 0.060 |
Why?
|
| Cell Line | 3 | 2009 | 2484 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 393 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2006 | 55 | 0.060 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 85 | 0.060 |
Why?
|
| Viral Plaque Assay | 1 | 2006 | 17 | 0.060 |
Why?
|
| Intestine, Small | 1 | 1988 | 321 | 0.060 |
Why?
|
| Cell Fusion | 1 | 2006 | 34 | 0.060 |
Why?
|
| Giant Cells | 1 | 2006 | 18 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 212 | 0.060 |
Why?
|
| Cholesterol | 1 | 1988 | 377 | 0.060 |
Why?
|
| Models, Biological | 3 | 2008 | 1806 | 0.060 |
Why?
|
| Hypertension | 1 | 1992 | 791 | 0.060 |
Why?
|
| Erythrocyte Membrane | 1 | 2006 | 61 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 1102 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 995 | 0.060 |
Why?
|
| Time Factors | 4 | 2009 | 5586 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 318 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 215 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 2011 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2009 | 915 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2006 | 421 | 0.050 |
Why?
|
| Gene Expression | 2 | 2002 | 1322 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2014 | 712 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2006 | 170 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 489 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 1105 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 362 | 0.050 |
Why?
|
| Virus Replication | 1 | 2006 | 292 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2006 | 252 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2004 | 58 | 0.050 |
Why?
|
| Swine | 1 | 2006 | 593 | 0.050 |
Why?
|
| Insulin | 1 | 2009 | 1226 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2000 | 687 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2010 | 9806 | 0.050 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2002 | 7 | 0.050 |
Why?
|
| Activin Receptors, Type I | 1 | 2002 | 13 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 102 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2003 | 97 | 0.050 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2002 | 52 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2002 | 66 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 102 | 0.050 |
Why?
|
| Random Allocation | 1 | 2002 | 312 | 0.040 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 3 | 1997 | 7 | 0.040 |
Why?
|
| Cell Count | 1 | 2002 | 195 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 225 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2002 | 94 | 0.040 |
Why?
|
| Food, Organic | 1 | 2001 | 3 | 0.040 |
Why?
|
| Psychology, Social | 1 | 2001 | 8 | 0.040 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2000 | 7 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2000 | 43 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 895 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2000 | 145 | 0.040 |
Why?
|
| Membrane Proteins | 3 | 2010 | 1293 | 0.040 |
Why?
|
| Phosphoinositide Phospholipase C | 2 | 1997 | 7 | 0.040 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1999 | 10 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 1998 | 945 | 0.040 |
Why?
|
| Guanine | 1 | 1999 | 194 | 0.040 |
Why?
|
| Protein Kinase C-alpha | 4 | 1999 | 29 | 0.040 |
Why?
|
| Caspases | 2 | 2012 | 151 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1946 | 0.030 |
Why?
|
| Young Adult | 1 | 2011 | 7598 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 420 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3622 | 0.030 |
Why?
|
| Incidence | 1 | 2002 | 1798 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 1608 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 1997 | 15 | 0.030 |
Why?
|
| Tyrosine | 1 | 1997 | 135 | 0.030 |
Why?
|
| Cell Membrane | 3 | 1998 | 681 | 0.030 |
Why?
|
| Neoplasms | 1 | 2012 | 3382 | 0.030 |
Why?
|
| Enzyme Induction | 2 | 2012 | 83 | 0.030 |
Why?
|
| Cholic Acids | 1 | 1995 | 7 | 0.030 |
Why?
|
| Cell Movement | 2 | 2011 | 821 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 889 | 0.030 |
Why?
|
| Piroxicam | 1 | 1995 | 11 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1995 | 153 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 1994 | 9 | 0.030 |
Why?
|
| Intestines | 1 | 1998 | 442 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1994 | 27 | 0.030 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1994 | 2 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1994 | 167 | 0.030 |
Why?
|
| Zanthoxylum | 1 | 2014 | 9 | 0.030 |
Why?
|
| Zingiberaceae | 1 | 2014 | 10 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 1994 | 42 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2014 | 37 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2014 | 85 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1994 | 290 | 0.030 |
Why?
|
| Jejunum | 1 | 2014 | 78 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2014 | 137 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2014 | 90 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 1995 | 118 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1995 | 211 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 68 | 0.020 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2013 | 16 | 0.020 |
Why?
|
| Biosensing Techniques | 1 | 2014 | 84 | 0.020 |
Why?
|
| Microsomes | 1 | 1993 | 32 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2011 | 677 | 0.020 |
Why?
|
| Thumb | 1 | 1993 | 29 | 0.020 |
Why?
|
| Membrane Fluidity | 1 | 1992 | 9 | 0.020 |
Why?
|
| Vinblastine | 1 | 1992 | 84 | 0.020 |
Why?
|
| Daunorubicin | 1 | 1992 | 77 | 0.020 |
Why?
|
| Adult | 2 | 2011 | 29698 | 0.020 |
Why?
|
| Evans Blue | 1 | 1992 | 3 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 1992 | 33 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 201 | 0.020 |
Why?
|
| Rats, Inbred WKY | 1 | 1992 | 31 | 0.020 |
Why?
|
| Mucin-2 | 1 | 2012 | 12 | 0.020 |
Why?
|
| Arteries | 1 | 1993 | 172 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 293 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2012 | 24 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2001 | 3058 | 0.020 |
Why?
|
| Microvessels | 1 | 2012 | 70 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 2025 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2012 | 46 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1992 | 234 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 92 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2012 | 32 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2012 | 69 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1992 | 121 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 553 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2012 | 160 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2012 | 165 | 0.020 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2011 | 9 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 526 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1992 | 287 | 0.020 |
Why?
|
| Maleimides | 2 | 2003 | 26 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2011 | 90 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2012 | 114 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 125 | 0.020 |
Why?
|
| Peptides | 1 | 1994 | 671 | 0.020 |
Why?
|
| Estradiol | 1 | 2012 | 268 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 178 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 291 | 0.020 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2011 | 46 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 283 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1992 | 446 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 468 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 189 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2012 | 519 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2012 | 478 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 307 | 0.020 |
Why?
|
| Traction | 1 | 1989 | 8 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 341 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1989 | 30 | 0.020 |
Why?
|
| Indoles | 2 | 2003 | 340 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 1162 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2010 | 239 | 0.020 |
Why?
|
| Protein Kinase C beta | 2 | 1999 | 13 | 0.020 |
Why?
|
| Proteins | 1 | 2014 | 804 | 0.020 |
Why?
|
| DNA | 1 | 2014 | 1274 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1989 | 273 | 0.020 |
Why?
|
| Myosins | 1 | 1989 | 89 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 277 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1988 | 300 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 1988 | 41 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1564 | 0.020 |
Why?
|
| Liposomes | 1 | 1988 | 105 | 0.020 |
Why?
|
| Liver | 1 | 1992 | 1231 | 0.020 |
Why?
|
| Equipment Design | 1 | 1989 | 428 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1989 | 239 | 0.020 |
Why?
|
| Ulcer | 1 | 2007 | 38 | 0.020 |
Why?
|
| Lysosomes | 1 | 2008 | 126 | 0.020 |
Why?
|
| Adolescent | 1 | 2001 | 10168 | 0.020 |
Why?
|
| Permeability | 1 | 2007 | 145 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 1152 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2007 | 118 | 0.020 |
Why?
|
| RNA Interference | 1 | 2007 | 388 | 0.010 |
Why?
|
| Homeostasis | 1 | 2009 | 474 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1995 | 2023 | 0.010 |
Why?
|
| Substrate Specificity | 2 | 1998 | 373 | 0.010 |
Why?
|
| Contrast Media | 1 | 2010 | 1014 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2008 | 450 | 0.010 |
Why?
|
| Wound Healing | 1 | 2007 | 385 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1988 | 670 | 0.010 |
Why?
|
| Cytokines | 1 | 2009 | 890 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 122 | 0.010 |
Why?
|
| Enterotoxins | 2 | 1994 | 22 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 161 | 0.010 |
Why?
|
| Bacterial Toxins | 2 | 1994 | 112 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 840 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 1305 | 0.010 |
Why?
|
| Escherichia coli Proteins | 2 | 1994 | 186 | 0.010 |
Why?
|
| Water | 1 | 2004 | 309 | 0.010 |
Why?
|
| Adenosine Triphosphate | 2 | 1994 | 320 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 64 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2000 | 35 | 0.010 |
Why?
|
| Zinc | 1 | 2001 | 99 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2000 | 37 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 2000 | 64 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1999 | 26 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1999 | 34 | 0.010 |
Why?
|
| Curcumin | 1 | 1999 | 18 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 68 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 77 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 98 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 187 | 0.010 |
Why?
|
| Ionomycin | 1 | 1999 | 19 | 0.010 |
Why?
|
| Carbazoles | 1 | 1999 | 31 | 0.010 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 1999 | 16 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 1999 | 90 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 596 | 0.010 |
Why?
|
| Cell Survival | 1 | 2000 | 1018 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 994 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 1995 | 12 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 1995 | 10 | 0.010 |
Why?
|
| Ethers, Cyclic | 1 | 1995 | 8 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1995 | 51 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1995 | 58 | 0.010 |
Why?
|
| Estrenes | 1 | 1994 | 7 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1995 | 280 | 0.010 |
Why?
|
| Pyrrolidinones | 1 | 1994 | 15 | 0.010 |
Why?
|
| Terpenes | 1 | 1994 | 18 | 0.010 |
Why?
|
| Natriuretic Peptides | 1 | 1994 | 7 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1994 | 57 | 0.010 |
Why?
|
| Staurosporine | 1 | 1994 | 34 | 0.010 |
Why?
|
| Alkaloids | 1 | 1994 | 48 | 0.010 |
Why?
|
| Pirenzepine | 1 | 1994 | 6 | 0.010 |
Why?
|
| Diamines | 1 | 1994 | 9 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 1994 | 17 | 0.010 |
Why?
|
| Atropine | 1 | 1994 | 53 | 0.010 |
Why?
|
| ras Proteins | 1 | 1995 | 137 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1989 | 11104 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1994 | 84 | 0.010 |
Why?
|
| Muscarinic Antagonists | 1 | 1994 | 60 | 0.010 |
Why?
|
| Alamethicin | 1 | 1993 | 1 | 0.010 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 1993 | 9 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 1993 | 13 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1993 | 18 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1993 | 34 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 1993 | 57 | 0.010 |
Why?
|
| Stearates | 1 | 1992 | 1 | 0.010 |
Why?
|
| Benzyl Alcohols | 1 | 1992 | 2 | 0.010 |
Why?
|
| Benzyl Alcohol | 1 | 1992 | 3 | 0.010 |
Why?
|
| Piperidines | 1 | 1994 | 177 | 0.010 |
Why?
|
| Bile Acids and Salts | 1 | 1993 | 78 | 0.010 |
Why?
|
| Microsurgery | 1 | 1993 | 122 | 0.010 |
Why?
|
| Biological Transport | 1 | 1992 | 402 | 0.010 |
Why?
|
| Aged | 1 | 2002 | 21986 | 0.000 |
Why?
|